AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-006763 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
24,854
Total Value
$24,962.26
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer and Chief Legal Officer | Common Stock | โ | Jan 5, 2026 | Sale | 17,923 | $1.00 | $17,948.09 | 159,430 | Direct | โ | View Details | |
Chief Operating Officer and Chief Legal Officer | Common Stock | โ | Jan 6, 2026 | Sale | 6,931 | $1.01 | $7,014.17 | 152,499 | Direct | โ | View Details |